Adenovirus-mediated expression of human CD59 on xenogeneic endothelial cells: Protection against human complement-mediated lysis and induction of cellular activation by adenoviral transduction

Xenotransplantation

Volumn 4, Issue 4, 1997, Pages 212-221

  Charreau, Béatrice ^a   Tesson, Laurent ^a   David, Anne ^a   Cassard, Armelle ^a   Quantin, Béatrice ^a   Pavirani, Andrea ^b   Soulillou, Jean Paul ^a   Anegon, Ignacio ^a  

^a INSERM   (France)

^b TRANSGENE S A   (France)

Author keywords

Adenoviral vector; Cellular activation; Complement; Endothelial cells; Transplantation

Indexed keywords

EID: 0012433531     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1997.tb00185.x     Document Type: Article

References (42)

1. SOMMERVILLE CA, D'APICE JF. Future directions in transplantation: Xenotransplantation. Kidney Int 1993; 44:S112.
2. DALMASSO AP. The complement in Xenotransplantation. Immunopharmacology 1992; 24:149.
3. MORGAN BP, MERI S. Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 1994; 15:369.
4. CHARREAU B, CASSARD A, TESSON L, LE MAUFF B, NAVENOT J-M, BLANCHARD D, LUBLIN D, SOULILLOU J-P, ANEGON I. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Transplantation 1994; 58:1222.
5. KENNEDY SP, ROLLINS SA, BURTON WV, SIMS PJ, BOTHWELL AL, SQUINTO SP, ZAVOICO GB. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by human CD59. Transplantation 1994; 57:1494.
6. FODOR WL, WILLIAMS BL, MATIS LA, MAORI JA, ROLLINS SA, KNIGHT JW, VELANDER W, SQUINTO SP. Expression of a functional human complement inhibitor in a transgenic pug as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91:11153.
7. MCCURRY K, KOOYMAN DL, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS, PLATT JL. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Med 1995; 1:423.
8. BERKNER KL. Expression of heterologous sequences in adenoviral vectors. Curr Top Microbiol Immunol 1992; 158:39.
9. ANEGON I, DAVID A, CHARREAU B, SOULILLOU J-P. Somatic gene transfer in transplantation. In Transplantation Biology. Cellular and Molecular Aspects. N.L. Tilney, T.B. Strom, L.C. Paul, eds. New York: Raven Press, 1996; 689.
10. YANG Y, ERTL HC, WILSON JM. MHC Class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenovirus. Immunity 1994; 1:433.
11. YANG Y, NUNES FA, BERENCSI K, FURTH EE, GÖNCZÖL E, WILSON JM. Cellular immunity to viral antigens limits E1-deleted adenovirus for gene therapy. Proc Natl Acad Sci USA 1994; 91:4407.
12. RUSHMERE NK, HARRISON RA, VAN DEN BERG CW, MORGAN BP. Molecular cloning of the rat analogue of human CD59: Structural comparison wtih human CD59 and identification of a putative active site. Biochem J 1994; 304:595.
13. TAKIZAWA H, OKADA N, OKADA H. Complement inhibitor of rat cell membrane resembling mouse Crry/p65. J Immunol 1994; 152:3032.
14. GRAHAM FL, PREVEC L. Manipulation of adenovirus vectors. In: Murray EJ, ed. Methods in Molecular Biology. Clifton, NJ:, 1991; 109.
15. STRATFORD-PERRICAUDET LD, MAKEH I, PERRICAUDET M, BRIAND P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992; 90:626.
16. VOYTA JC, VIA DP, BUTTERFIELD CE, ZETTER BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99:2034.
17. JAFFE EA, NACHMAN RL, BECKER CG, MINICK CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52:2745.
18. DECKERT M, KUBAR J, ZOCCOLA D, BERNARD-POMIER G, ANGELISOVA P, HOREJSI V, BERNARD A. CD59 molecule: A second ligand for CD2 in T cell adhesion. Eur J Immunol 1992; 22:2943.
19. CHOMCZYNSKY P, SACCHI N. Single-step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 62:156.
20. YUN TSO J, XIAO-HONG SUN, TEH-HUI KAO, REECE K, WU R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexicity and molecular evolution of the gene. Nucl Acids Res 1985; 13:2485.
21. ETIXGIN OR, SYLVERSTEIN RL, HAJJAR DP. Von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993; 90:5153.
22. JONES K, RIVERA C, SGADARI C, FRANKLIN J, MAX EE, BHATIA K, TOSATO G. Infection of human endothelial cells with Epstein-Barr virus. J Exp Med 1995; 182:1213.
23. SEDMARK DD, KNIGHT DA, VOOK NC, WALDMAN JW. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells. Transplantation 1994; 58:1379.
24. FRIEDMAN HM. Infection of endothelial cells by common human viruses. Rev Infect Dis 1989; II:S700.
25. QIN JE, CHAVIN KD, DING Y, FAVARO JP, WOODWARD JE, LIN J, TAHARA H, ROBBINS P, SHAKED A, HO DY, SAPOLSKY MT, LOTZE MT, BROMBERG JS. Multiple vectors effectively achieve gene transfer in a murine cardiac transplantation model. Transplantation 1995; 59:809.
26. HEIKKILÄ P, PARPALA T, LUKKARINEN O, WEBER M, TRYGGVASON K. Adenovirus-mediated gene transfer inti kidney glomeruli using an ex vivo and in vivo kidney perfusion system: First steps towards gene therapy of Alport syndrome. Gene Ther 1996; 3:21.
27. KAWAGISHI M, RYDBERG L, SAMUELSSON BE, TIBELL A, GROTH CG, MÖLLER E. Limited specificity of xenoantibodies in diabetic patients transplanted with fetal porcine islet cell clusters: Main antibody reactivity against α-linked galactose-containing epitopes. Xenotransplantation 1994; 1:89.
28. GALILI U. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: A major obstacle for xenotransplantation in humans. Immunol Today 1993; 14:480.
29. VAN DEN BERG CW, MORGAN BP. Complement-inhibiting activities of human CD59 and analogues from rat, sheep, and pig are not homologously restricted. J Immunol 1994; 152:4095.
30. GERRITSEN ME, BLOOR CM. Endothelial cell gene expression in response to injury. Faseb J 1993; 7:523.
31. POBER JS, COTRAN RS. The role of endothelial cells in inflammation. Transplantation 1990; 50:537.
32. MOUTABARRICK A, NAKANISHI I, NAMIKI M, HARA T, MATSUMOTO M, ISHIBASHI M, OKUYAMA A, ZAID D, SEYA T. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46 (MCP), CD55 (DAF), and CD59 on human vascular endothelial cells. Lymph Cyt Res 1993; 12:167.
33. WRIGHTON CJ, HOFER-WARBINEK R, MOLL T, EYTNER R, BACH FH, DE MARTIN R. Inhibition of endothelial cell activation by adenovirus-mediated expression of IkBa, an inhibitor of the transcription factor NF-κB. J Exp Med 1996; 183:1013.
34. AMIN R, WILMOTT R, SCHWARZ Y, TRAPNELL B, STARK J. Replication-deficient adenovirus induces expression of Interleukin-8 by airway epithelial cells in vitro. Hum Gene Ther 1995;6:145.
35. GOODMAN DJ, VON ALBERTINI MA, MCSHEA A, WRIGHTON CJ, BACH FH. Adenoviral-mediated overexpression of IκBα in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 1996; 7:967.
36. 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73:309.
37. HYNES RO. Integrins: Versality, modulation, and signaling in cell adhesion. Cell 1992; 69:11.
38. SPERGEL JM, HSU W, AKIRA S, THIMMAPPAYA B, KISHIMOTO T, CHEN-KIANG S. NF-IL6, a member of the C/EBP family, regulates E1 A-responsive promoters in the absence of E1A. J Virol 1992; 66:1021.
39. PÄÄBO S, NILSSON T, PETERSON PA. Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens. Proc Natl Acad Sci USA 1986; 83:9665.
40. ROSENTHAL A, WRIGHT S, QUADE K, GALLIMORE P, CEDAR H, GROSVELD F. Increased MHC H-2K gene transcription in cultured mouse embryo cells after adenovirus infection. Nature 1985; 315:579.
41. DAI Y, SCHWARZ EM, GU D, ZHANG W-W, SARVENITNICK N, VERMA I. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92:1401.
42. ENGELHARDT JF, YE X, DORANZ B, WILSON JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994; 91:6196.